IP Verse

Antibodies With Modified Affinity To Fcrn That Promote Antigen Clearance - EP2552955B1

PatentPatent Analysis

EP2552955

CHUGAI SEIYAKU KABUSHIKI KAISHA
Application Number
EP11714860A
Filing Date
Mar 30, 2011
Status
Revoked
Sep 23, 2022
Grant Date
May 3, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3181581B1
EP3296395B2
EP3202785B1

Bibliography

The patent EP2552955B1 was granted to Chugai Seiyaku Kabushiki Kaisha on May 3, 2017 following the initial filing on Mar 30, 2011 under the application number EP11714860A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SHIRE HUMAN GENETIC THERAPIESFeb 5, 2018ADMISSIBLE
TILLOTTS PHARMAFeb 5, 2018ADMISSIBLE
ABLYNXFeb 2, 2018ADMISSIBLE
GLAXO GROUPFeb 2, 2018ADMISSIBLE
MURPHYFeb 2, 2018ADMISSIBLE
ALEXION PHARMACEUTICALSFeb 2, 2018WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents